GSK Investigational Site

Rovigo, Veneto 45100

0 studies enrolling now · 1 studies all time

What they study most

Infection, Human Immunodeficiency Virus I

Studies at this site

• A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily — Completed